Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Health Canada Approves Ceftobiprole Medocaril for Treatment of Complicated Skin Structure Infections NEW YORK -- September 2, 2008 -- Health Canada has approved ceftobiprole medocaril IV (Zeftera) for the treatment of complicated skin and skin structure infections (cSSSI), including non-limb-threatening diabetic foot infections without concomitant osteomyelitis. Ceftobiprole medocaril IV is also effective against methicillin-resistant Staphylococcus aureus (MRSA). The approval was based on results of 2 phase 3, double-blind, randomised, multicentre, global trials involving 817 patients with cSSSI. The first study demonstrated the efficacy of ceftobiprole medocaril compared with vancomycin alone in patients with suspected or confirmed gram-positive cSSSI, and a second study demonstrated the effectiveness of ceftobiprole medocaril when compared with vancomycin plus ceftazidime. The second phase 3 trial included patients with non-limb-threatening diabetic foot infections. Pathogens identified at baseline in this subpopulation included methicillin-sensitive S. aureus (38%), MRSA (13%), Enterobacter cloacae (9%), and Proteus mirabilis (7%). The results demonstrated the effectiveness of ceftobiprole medocaril when compared with vancomycin plus ceftazidime. In both studies, ceftobiprole medocaril was well tolerated. The most common treatment-emergent adverse reactions were nausea (9%), taste disturbance (6%), diarrhoea (5%), and vomiting (5%). SOURCE: Environics Communications Press Release E-mail this page to a friend or colleague! To print, use this version